Extramedullary accumulation of myeloblasts or immature myeloid cells form tumors called myeloid sarcoma in the WHO classification. Such tumors develop in lymphoid organs, bone (skull, orbit, etc.), skin, soft tissue, various mucosae and organs, and the CNS. They may precede or occur concurrently with acute myeloid leukemia, or reveal blastic transformation of chronic myeloproliferative disorders or myelodysplastic syndromes. They may also reveal relapses in treated patients. They are constituted by a diffuse infiltrate made up of medium-to-large cells. The cells are difficult to identify. Imprints are very useful. Immunohistochemistry can help diagnose and distinguish four variants: granulocytic myeloperoxidase (MPO+, CD 68+ [KP1, PGM1-] lysozyme+, CD 34), monoblastic (MPO-, CD 68+, [KPI+, PGMI+] lysozyme+, CD 34-), myelomonoblastic (MPO-, CD 68+, [KPI+, PGM1+] lysozyme+, CD 34-), or megakaryoblastic (positivity for factor VIII, CD 61, CD 31). Immunohistochemistry sometimes demonstrates expression of CD 43, CD 7, CD 79a, and CD 56 (particularly the monoblastic variant with t[8;2 1]). Recently the demonstration of CD 99 and CD 1 7, which can now be done on paraffin sections, may be useful to identify blasts of granulocytic origin. The diagnosis is missed in about 50% of cases when immunohistochemistry is not used. Patients with myeloid sarcomas should be treated in the same way as patients with acute myeloblastic leukemia. Disease progression and prognosis are similar for the two conditions.
1. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds.): World Health Organization classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. IARC Press: Lyon, pp. 104-105, 2001
2.
2. Neiman RS, Barcos M, Berard C, Bonner H, Mann R, Rydell RE, Bennett JM. Granulocytic sarcoma. A clinicopathologic study of 61 biopsied cases. Cancer48:1426-1437, 1981
3.
3. Somjee S, Borker A, Gardner R, Velez MC. Multiple granulocytic sarcomas in acute myeloblastic leukemia with simultaneous occurrence of t(8:21) and trisomy 8. Leuk Lymphoma42:1139-1144, 2001
4.
4. Byrd JC, Weiss RB. Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule. Cancer. 73:2107-2112, 1994
5.
5. Lin Y, Govindan R, Hess JL. Malignant hematopoietic breast tumors. Am J Clin Pathol107:177-186, 1997
6.
6. Oliva E, Ferry JA, Young RH, Prat J, Srigley JR, Scully RE. Granulocytic sarcoma of the female genital tract: A clinicopathologic study of 11 cases. Am J Surg Pathol21:1156-1165, 1997
7.
7. Billio A, Pianezze G, Amato B, Fabris P. "Isolated" peritoneal granulocytic sarcoma with molecular and chromosomal bone marrow involvement. Haematologica87:EIMO1-EIM01, 2002
8.
8. Ponzoni M, Patriarca C, Arrigoni G, Gianelli U, Vicari A, Folli F. Extramedullary myeloid cell tumor/granulocytic sarcoma with predilection for serosal surfaces. Haematologica87:ECRO9-ECR09, 2002
9.
9. Ravandi-Kashani F, Cortes J, Giles FJ. Myelodysplasia presenting as granulocytic sarcoma of mediastinum causing superior vena cava syndrome. Leukemia Lymphoma365:631-637, 2000
10.
10. Stockl FA, Dolmetsch AM, Saornil MA, Font RL, Burnier MN Jr. Orbital granulocytic sarcoma. Br J Ophthalmol81:1084-1088, 1997
11.
11. Tanigawa M, Tsuda Y, Amemiya T, Yamada K, Nakayama M, Tsuji Y. Orbital tumor in acute myeloid leukemia associated with karyotype 46,XX,t(8;21)(q22;q22): A case report. Ophthalmologica212:202-205, 1998
12.
12. Buckland ME, Scolyer RA, Donellan MB, Brew S, McGee-Collett M, Harper CG. Spinal chloroma presenting with triplegia in an aleukaemic patient. Pathology33:386-389, 2001
13.
13. Ugras S, Cirak B, Karakok M, Guven B. Spinal epidural granulocytic sarcoma (chloroma) in a non-leukemic child. Pediatr Int43:505-507, 2001
14.
14. Psiachou-Leonard E, Paterakis G, Stefanaki K, Mikraki-Christou V, Haidas S. Cerebellar granulocytic sarcoma in an infant with CD56+ acute monoblastic leukemia. Leuk Res25:1019-1021, 2001
16. Specchia G, Palumbo G, Pastore D, Mininni D, Mestice A, Liso V. Extramedullary blast crisis in chronic myeloid leukemia. Leukemia Res20:905-908, 1996
17.
17. Bekassy AN, Hermans J, Gorin NC, Gratwohl A. Granulocytic sarcoma after allogeneic bone marrow transplantation: A retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 17:801-808, 1996
18.
18. Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E. Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer85:608-615, 1999
19.
19. Martel L, Reddy K, Greco M, Tuscano M, Richman M, Wun T. Isolated cavernous sinus extramedullary relapse of chronic myelogenous leukemia following allogeneic stem cell transplant. Ann Hematol81:108-110, 2002
20.
20. Szomor A, Passweg JR, Tichelli A, Hoffmann T, Speck B, Gratwohl A. Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation. Ann Hematol75:239-241, 1997
21.
21. Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: Report of two cases and a review of 72 cases in the literature. Cancer94:1739-1746, 2002
23. Strauchen JA, Gordon RE. Crystalline inclusions in granulocytic sarcoma. Arch Pathol Lab Med126:85-86, 2002
24.
24. Hirose Y, Masaki Y, Shimoyama K, Sugai S, Nojima T. Granulocytic sarcoma of megakaryoblastic differentiation in the lymph nodes terminating as acute megakaryoblastic leukemia in a case of chronic idiopathic myelofibrosis persisting for 16 years. Eur J Haematol67:194-198, 2001
25.
25. Chang CC, Eshoa C, Kampalath B, Shidham VB, Perkins S. Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow. Am J Clin Pathol114:807-811, 2000
26.
26. Quintinilla-Martinez L, Zukerberg LR, Ferry JA, Harris NL. Extramedullary tumors of lymphoid or myeloid blasts. The role of immunohistology in diagnosis and classification. Am J Clin Pathol104: 431-443, 1995
27.
27. Zhang PJ, Barcos M, Stewart CC, Block AW, Sait S, Brooks JJ. Immunoreactivity of MIC2 (CD99) in acute myelogenous leukemia and related disease. Mod Pathol13:452-458, 2000
28.
28. Murakami Y, Nagae S, Matsuishi E, Irie K, Furue M. A case of CD56+ cutaneous aleukaemic granulocytic sarcoma with myelodysplastic syndrome. Br J Dermatol143:587-590, 2000
29.
29. Seymour JF, Pierce SA, Kantarjian HM et al. Investigation of karyotypic, morphologic, and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia8:823-826, 1994
30.
30. Suzuki R, Yamamoto K, Seto M, Kagami Y, Ogura M, Yatabe Y, Suchi T, Kodera Y, Morishima Y, Takahashi T, Saito H, Ueda R, Nakamura S. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: A distinct hematolymphoid disease entity. Blood90:2417-2428, 1997
31.
31. Fickers M, Theunissen P. Granulocytic sarcoma with expression of CD30. J Clin Pathol49:762-763, 1996
32.
32. Krishnan K, Ross CW, Adams PT, Pereira A, Roth MS. Neural cell-adhesion molecule (CD 56)-positive, t(8;21) acute myeloid leukemia (AML, M-2) and granulocytic sarcoma. Ann Hematol69:321-323, 1994
33.
33. Russel SJ, Giles FJ, Thompson DS, Scanlon DJ, Walker H, Richards JDM. Granulocytic sarcoma of the small intestine preceding acute myelomonocytic leukemia with abnormal eosinophils and inv(16). Cancer Genet Cytogenet35:231-235, 1988
34.
34. Johansson B, Fioretos T, Kullendorff CM, Wiebe T, Bekassy AN, Garwicz S, Forestier E, Roos G, Akerman M, Mitelman F, Billstrom R. Granulocytic sarcomas in body cavities in childhood acute myeloid leukemias with 1 Iq23/MLL rearrangements. Genes Chromosomes Cancer27:136-142, 2000
35.
35. Park KU, Lee DS, Lee HS, Kim CJ, Cho HI. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: Fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement. Am J Pathol159:2011-2016, 2001
36.
36. Thirman MJ, Gill HJ, Burnett HC, Mbangkollo D, McCabe NR, Kobayashi H, Zienin-Van D, Poel S, Kaneko?, Norgan?, Sandberg AA. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 1 1q23 chromosomal translocations. N Engl J Med329:909-914, 1993
37.
37. Heimann P, Vamos E, Ferster A, Sariban E. Granulocytic sarcoma showing chromosomal changes other than the t(8;21). Cancer Genet Cytogenet74:59-61, 1994
38.
38. Ishii E, Eguchi M, Matsuzaki A, Zaizen Y, Yoshidomi S, Kimura N, Takeshita M, Tashiro S, Kamada N, Suita S, Ueda K, Miyazaki S. Granulocytic sarcoma in infant with MLL rearrangement preceding acute monoblastic leukemia with t (10; I 1) (p1 1; q2 3). Leukemia11:1970-1974, 1995
39.
39. Kobayashi H, Hosada F, Maseki N, Sakurai M, Imashuku S, Ohki M, Kaneko Y. Hematologic malignancies with the t(10;11)(pl3;q21) have the same molecular event and a variety of morphologic or immunologic phenotypes. Genes Chromosomes Cancer20:253-259, 1997
40.
40. Myint H, Chacko J, Mould S, Ross F, Oscier DG. Karyotypic evolution in a granulocytic sarcoma developing in a myeloproliferative disorder with a novel (3;4) translocation. Br J Haematol90:462-464, 1995
41.
41. Schwarz J, Trnkova Z, Bedrlikova R, Jirasek A, Zakova D, Trneny M, Sedlackova E, Kodetova D, Valenta J, Stockbauer P, Haskovec C, Soukup J. Aleukemic granulocytic sarcoma with AMLI/ETO fusion gene expression and clonal T cell populations. Leuk Res25:1137-1142, 2001
42.
42. Galanis E, Li CY, Phyliky R. Mast cell disease mimicking granulocytic sarcoma. Am J Hematol56:194-195, 1997
43.
43. Vasef MA, Neiman RS, Meletiou SD, Platz CE. Marked granulocytic proliferation induced by granulocyte colony-stimulating factor in the spleen simulating a myeloid leukemic infiltrate. Mod Pathol11:1138-1141, 1998
44.
44. Byrd JC, Weiss RB, Arthur DC, Lawrence D, Baer MR, Davey F, Trikha ES, Carroll AJ, Tantravahi R, Qumsiyeh M, Patil SR, Moore JO, Mayer RJ, Schiffer CA, Bloomfield CD. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from Cancer and Leukemia Group B 8461. J Clin Oncol15:466-475, 1997
